Searchable abstracts of presentations at key conferences in endocrinology

ea0016p205 | Diabetes and cardiovascular diseases | ECE2008

Glycemic variability analyze with different glucometers

de Pinillos Guillermo Martinez , Maraver Silvia , Serrano Isabel , Morales Cristobal , Cuesta Carmen , Sendon Angel

Introduction: Currently self-glycemic control by the patient is essential to achieve a right metabolic control of diabetes. Nowadays, there are different systems that have proved useful for this aim.Objectives: Valuing any possible differences between systems and the relation with glycemia identified in our laboratory.Material and methods: We took blood samples by vein-puncture to 41 patients, and simultaneously we measured capilla...

ea0016p186 | Diabetes and cardiovascular diseases | ECE2008

Comparison of patient's life quality between inhalated insulin therapy (Exubera) and conventional treatment

Tome Monica , Serrano Isabel , Morales Cristobal , Maraver Silvia , Martinez de Pinillos Guillermo , Garcia-Quiros Juan Manuel , Cuesta Carmen , Sendon Angel

Objectives: To evaluate satisfaction with treatment in diabetic patients under therapy with inhaled insulin (exubera).Material and methods: Thirty-seven diabetic patients were evaluated, 27DM1 (75%) and 9DM2 (25%) that initiated treatment with Insulin inhaled (EXUBERA) between August and October 2007. Twenty-five men (69.4%) and 11 women (30.56%), between 18 and 71 years old (38.4±16.4) and with a time of evolution of diabetes between 0 and 47 years...

ea0016p187 | Diabetes and cardiovascular diseases | ECE2008

Satisfaction degree and metabolic control in patients with glucose continuous monitoring system

Morales Cristobal , Martinez de Pinillos Guillermo , Garcia-Quiros Juan Manuel , Tome Monica , Maraver Silvia , Serrano Isabel , Cuesta Carmen , Sendon Angel

Objective: To study the improvement of metabolic control and patients satisfaction with glucose continuous monitoring systems (Guardian real time).Material and method: Fifteen DM1 patients studied (age: 33.8±13.40, years of evolution: 17.06±11.32) in intensive treatment (5 multidoses, 10 insulin pump) which were made one 4 days long blind monitoring Period 1 (blind period) with sensor CGMS Gold. Next another monitoring was made with a real time...

ea0016p188 | Diabetes and cardiovascular diseases | ECE2008

Metabolic control and quality of life in patients with DM1 and insulin pump therapy

Serrano Isabel , Morales Cristobal , Maraver Silvia , Martinez de Pinillos Guillermo , Garcia-Quiros Juan Manuel , Tome Monica , Cuesta Carmen , Sendon Angel

Objectives: To value the quality of life improvement and metabolic control in patients with DM1 in the 2 first years of treatment with insulin pump therapy.Material and methods: We studied 33 DM1 patients, 16 men (48.5%) and 17 women (51.5%), with average age of 34.2±12.2 and 16.3±10.21 years of disease. Pump indication was hypoglycemia in 10 (30.3%), badly metabolic control in 14 (42.4%), pregnancy in 5 (15.2%) and glycemic inestability in 4 (...

ea0016p189 | Diabetes and cardiovascular diseases | ECE2008

Utility of ambulatory blood pressure monitoring in diabetological consulting

Garcia-Quiros Juan Manuel , Serrano Isabel , Morales Cristobal , Martinez de Pinillos Guillermo , Maraver Silvia , Tome Monica , Cuesta Carmen , Sendon Angel

Objectives: To check possible advantages of ambulatory blood pressure monitoring (ABPM) in diagnosis and disease control respect to blood pressure conventional measurement ways.Also to study the circadian rhythm of each patient to detect higher cardiovascular risk situations.Material and methods: One hundred and nine patients were included in this study: 44% male, 56% female. ABPM were indicated in four different situations: hypert...

ea0022p333 | Diabetes | ECE2010

Therapy with exenatide: our experience

Fernandez Ignacio , Morales Cristobal , De Quiros Juan Manuel Garcia , Tome Monica , Garcia Clara , Serrano Isabel , De La Cuesta Carmen , Sendon Angel

Objectives: Verify the efficacy of the GLP-1 analogue exenatide in patients with type 2 DM assisted in our hospital area.Material and methods: This study included patients who initiated this therapy in 2008 and 2009. Through 3 months were analyzed the outcomes of weight, HbA1c and the development of adverse effects.Results: The process included 32 patients, 21 men and 11 women, with ages between 26 and 73 years old (mean age 48.78 ...

ea0016p185 | Diabetes and cardiovascular diseases | ECE2008

Metabolic improvement in diabetic patients under education before implantation of the insulin sibcutaneous continuous infusion (ISCI)

Maraver Silvia , Martinez de Pinillos Guillermo , Morales Cristobal , Garcia-Quiros Juan Manuel , Tome Monica , Serrano Isabel , Garcia Teresa , Cuesta Carmen , Sendon Angel

Introduction: ISCI treatment is useful to optimize treatment in patients with DM1. Before implantation, is necessary the education of patients, as in technical aspects so in the handling of diabetes with this therapy.Objective: Evaluate the results of the diabetological education previous to the implantation of the ISCI and the repercussion of this program in patients metabolic control.Material and method: Forty-seven diabetic pati...

ea0016p729 | Thyroid | ECE2008

Valuation of iodine deficiency in Western Andalusia by means of the neonatal screening of congenital hypothyroidism

Garcia-Quiros Juan Manuel , Morales Cristobal , Maraver Silvia , Martinez de Pinillos Guillermo , Tome Monica , Cuesta Carmen , Guerrero J M , Sendon Angel

Introduction: The accomplishment of screening neonatal congenital hypothyroidism allows the use of the determination of TSH in new born (NB) like indirect marker of the iodine ingestion of the pregnant woman and the nutritional iodine deficiency in the population. In populations with a sufficient iodine ingestion, the proportion of children with TSH superior to 5 U/ml is smaller of 3%.Primary target: To make the iodine deficiency map in the studied area ...